GlycoGenesys Inc.

Public Company, Headquarters Location
31 St. James Ave, 8th Fl., Boston, MA 02116-4101, United States
(800)260-6843, (617)422-0674, (617)422-0675 fax,

Primary SIC: Biological Products Except Diagnostic, Primary NAICS: Biological Product (except Diagnostic) Manufacturing
Description: Manufacturing: Novel pharmaceutical products based on carbohydrate compounds.

View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!

GlycoGenesys Inc., News and Information

Appointments And Advancements.
BIOWORLD Today; 11/4/2009; 873 words; ...president, sales. Endo Pharmaceuticals Inc., of Chadds Ford, Pa., named...operating officer. EraGen Biosciences Inc., of Madison, Wis., appointed...marketing and corporate communications. GlycoGenesys Inc., of Boston, added Philip Kantoff...

Other News To Note.
BIOWORLD Today; 11/3/2009; 2565 words; ...antagonist technologies to Genentech Inc., of South San Francisco. Abnormal...June 12, 2003.) o CV Therapeutics Inc., of Palo Alto, Calif., intends...medicinal chemistry agreement. o GlycoGenesys Inc., of Boston, began a Phase I dose...

Pro-Pharmaceuticals Prevails in Trade Secret Lawsuit.
Business Wire; 7/17/2009; 1302 words; ...prosecuted by Prospect Therapeutics, Inc. ("Prospect") against the...Officer, Pro-Pharmaceuticals, Inc. We believe the termination...According to Pro-Pharmaceuticals, Inc., Prospect purchased certain...including this lawsuit, from the GlycoGenesys bankruptcy estate and continued...

Research and Markets: Cytotoxic Therapies, Camptosar, Eloxatin and Xeloda Are Some of the Product Segments Analyzed Inside the 2006 Global Strategic Business Report On Colorectal Cancer (CRC) Therapeutics.
Business Wire; 12/1/2006; 1043 words; ...Inc (Canada) - Genentech, Inc (USA) - Genvec, Inc (USA) - Genzyme Corporation (USA) - Glaxosmithkline PLC (UK) - GlaxoSmithKline, Inc (USA) - Glycogenesys, Inc (USA) - Idera Pharmaceuticals, Inc (USA) - IDM...

A DRUG ADRIFT
The Boston Globe; 8/22/2006; 788 words; ...company that owned it, Glycogenesys Inc., in the fall of 1999...litigation. In the end, Glycogenesys had the compound, but...rights. They still do. Glycogenesys ran out of money before...Research and Development Inc., and filed in US...

Why Purchase This Company Profile?

  • Sales prospecting
  • Competitive analysis
  • Vendor & supplier evaluation
  • Customer evaluation and analysis
  • Strategic planning

Need More Information?

Start a new search

Tell Us What You Think

Take our short survey to tell us what would make Goliath more valuable to you.

Add Your Company Information to Goliath
If your company does not appear in Goliath, click here to add it.

Update Your Company Information
If your company information has changed or is not correct,
click here to let us know.